# Rosanna Coppo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rosanna-coppo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,019 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 70 |
| i10-index | 195 |
| Last Known Institution | Fondazione Ricerca Molinette |
| OpenAlex ID | https://openalex.org/A5009096793 |
| ORCID iD | 0000-0003-4713-6282 |
| Works | 426 |

## Researcher papers

Showing 12 of 19.

- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Genome-wide association study identifies susceptibility loci for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-study-identifies-susceptibility-loci-for-iga-nephropathy/)
- [An international consensus approach to the management of atypical hemolytic uremic syndrome in children](https://scholariq.org/papers/an-international-consensus-approach-to-the-management-of-atypical-hemolytic/)
- [Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments](https://scholariq.org/papers/validation-of-the-oxford-classification-of-iga-nephropathy-in-cohorts-with/)
- [Evaluating a New International Risk-Prediction Tool in IgA Nephropathy](https://scholariq.org/papers/evaluating-a-new-international-risk-prediction-tool-in-iga-nephropathy/)
- [Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial](https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/)
- [Dynamics of complement activation in aHUS and how to monitor eculizumab therapy](https://scholariq.org/papers/dynamics-of-complement-activation-in-ahus-and-how-to-monitor-eculizumab-therapy/)
- [A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy](https://scholariq.org/papers/a-multicenter-study-of-the-predictive-value-of-crescents-in-iga-nephropathy/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Fondazione Ricerca Molinette](https://scholariq.org/institutions/fondazione-ricerca-molinette/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.